Myeloid-derived suppressor cells are proinflammatory and regulate collagen-induced arthritis through manipulating Th17 cell differentiation

Clinical Immunology

Volumn 157, Issue 2, 2015, Pages 175-186

  Zhang, Hui ^a   Wang, Shuang ^a   Huang, Yuefang ^a   Wang, Hongyue ^a   Zhao, Jijun ^a   Gaskin, Felicia ^b   Yang, Niansheng ^a   Fu, Shu Man ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Collagen induced arthritis; IL 1 ; Myeloid derived suppressor cells; Th17 cells

Indexed keywords

CD11B ANTIGEN; CD3 ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY CD28; COLLAGEN TYPE 2; IL17A PROTEIN, MOUSE; IL1B PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BONE EROSION; BONE MARROW CELL; CARTILAGE DEGENERATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL INFILTRATION; CELL PROLIFERATION; CELL TRANSFER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DAS28; DENDRITIC CELL; DISEASE SEVERITY; DOWN REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; MACROPHAGE; MALE; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SPLEEN CELL; SUPPRESSOR CELL; SYNOVIUM; T LYMPHOCYTE; TH17 CELL; ANIMAL; CELL CULTURE; CHEMICALLY INDUCED; CYTOLOGY; EXPERIMENTAL ARTHRITIS; IMMUNOLOGY; INFLAMMATION; MONONUCLEAR CELL; NEUTROPHIL;

ADOPTIVE TRANSFER; ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN TYPE II; HUMANS; INFLAMMATION; INTERLEUKIN-17; INTERLEUKIN-1BETA; LEUKOCYTES, MONONUCLEAR; MICE; MYELOID CELLS; NEUTROPHILS; TH17 CELLS;

EID: 84924292115     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2015.02.001     Document Type: Article

References (39)

1. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003, 423(6937):356-361.
2. Sokka T., Kautiainen H., Pincus T., Verstappen S.M., Aggarwal A., Alten R., et al. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthritis Res. Ther. 2010, 12(2):R42.
3. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 2009, 27:485-517.
4. McGeachy M.J., Cua D.J. Th17 cell differentiation: the long and winding road. Immunity 2008, 28(4):445-453.
5. Tesmer L.A., Lundy S.K., Sarkar S., Fox D.A. Th17 cells in human disease. Immunol. Rev. 2008, 223:87-113.
6. Sarkar S., Cooney L.A., White P., Dunlop D.B., Endres J., Jorns J.M., et al. Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4. Arthritis Res. Ther. 2009, 11(5):R158.
7. Ziolkowska M., Koc A., Luszczykiewicz G., Ksiezopolska-Pietrzak K., Klimczak E., Chwalinska-Sadowska H., et al. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J. Immunol. 2000, 164(5):2832-2838.
8. Kirkham B.W., Lassere M.N., Edmonds J.P., Juhasz K.M., Bird P.A., Lee C.S., et al. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum. 2006, 54(4):1122-1131.
9. Nakae S., Nambu A., Sudo K., Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 2003, 171(11):6173-6177.
10. Lubberts E., Koenders M.I., Oppers-Walgreen B., van den Bersselaar L., Coenen-de Roo C.J., Joosten L.A., et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 2004, 50(2):650-659.
11. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009, 9(3):162-174.
12. Ostrand-Rosenberg S., Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 2009, 182(8):4499-4506.
13. Marigo I., Dolcetti L., Serafini P., Zanovello P., Bronte V. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol. Rev. 2008, 222:162-179.
14. Gabrilovich D.I., Bronte V., Chen S.H., Colombo M.P., Ochoa A., Ostrand-Rosenberg S., et al. The terminology issue for myeloid-derived suppressor cells. Cancer Res. 2007, 67(1):425. (author reply 6).
15. Youn J.I., Nagaraj S., Collazo M., Gabrilovich D.I. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 2008, 181(8):5791-5802.
16. Peranzoni E., Zilio S., Marigo I., Dolcetti L., Zanovello P., Mandruzzato S., et al. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 2010, 22(2):238-244.
17. Haile L.A., von Wasielewski R., Gamrekelashvili J., Kruger C., Bachmann O., Westendorf A.M., et al. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 2008, 135:871-881. (81 e1-5).
18. Filipazzi P., Valenti R., Huber V., Pilla L., Canese P., Iero M., et al. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J. Clin. Oncol. 2007, 25(18):2546-2553.
19. Solito S., Falisi E., Diaz-Montero C.M., Doni A., Pinton L., Rosato A., et al. A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood 2011, 118(8):2254-2265.
20. Ioannou M., Alissafi T., Lazaridis I., Deraos G., Matsoukas J., Gravanis A., et al. Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease. J. Immunol. 2012, 188(3):1136-1146.
21. Delano M.J., Scumpia P.O., Weinstein J.S., Coco D., Nagaraj S., Kelly-Scumpia K.M., et al. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 2007, 204(6):1463-1474.
22. Makarenkova V.P., Bansal V., Matta B.M., Perez L.A., Ochoa J.B. CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J. Immunol. 2006, 176(4):2085-2094.
23. Zhu B., Bando Y., Xiao S., Yang K., Anderson A.C., Kuchroo V.K., et al. CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J. Immunol. 2007, 179(8):5228-5237.
24. King I.L., Dickendesher T.L., Segal B.M. Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 2009, 113(14):3190-3197.
25. Mildner A., Mack M., Schmidt H., Bruck W., Djukic M., Zabel M.D., et al. CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. Brain J. Neurol. 2009, 132(Pt 9):2487-2500.
26. Yi H., Guo C., Yu X., Zuo D., Wang X.Y. Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis. J. Immunol. 2012, 189(9):4295-4304.
27. Egelston C., Kurko J., Besenyei T., Tryniszewska B., Rauch T.A., Glant T.T., et al. Suppression of dendritic cell maturation and T cell proliferation by synovial fluid myeloid cells from mice with autoimmune arthritis. Arthritis Rheum. 2012, 64(10):3179-3188.
28. Gonzalez-Rey E., Chorny A., Varela N., O'Valle F., Delgado M. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells. Arthritis Rheum. 2007, 56(2):531-543.
29. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31(3):315-324.
30. Wing K., Onishi Y., Prieto-Martin P., Yamaguchi T., Miyara M., Fehervari Z., et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008, 322(5899):271-275.
31. Camps M., Ruckle T., Ji H., Ardissone V., Rintelen F., Shaw J., et al. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat. Med. 2005, 11(9):936-943.
32. Young M.R., Newby M., Wepsic H.T. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. Cancer Res. 1987, 47(1):100-105.
33. Xia S., Sha H., Yang L., Ji Y., Ostrand-Rosenberg S., Qi L. Gr-1+ CD11b+myeloid-derived suppressor cells suppress inflammation and promote insulin sensitivity in obesity. J. Biol. Chem. 2011, 286(26):23591-23599.
34. Kerr E.C., Raveney B.J., Copland D.A., Dick A.D., Nicholson L.B. Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations. J. Autoimmun. 2008, 31(4):354-361.
35. Fujii W., Ashihara E., Hirai H., Nagahara H., Kajitani N., Fujioka K., et al. Myeloid-derived suppressor cells play crucial roles in the regulation of mouse collagen-induced arthritis. J. Immunol. 2013, 191(3):1073-1081.
36. Leipe J., Grunke M., Dechant C., Reindl C., Kerzendorf U., Schulze-Koops H., et al. Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum. 2010, 62(10):2876-2885.
37. Pernis A.B. Th17 cells in rheumatoid arthritis and systemic lupus erythematosus. J. Intern. Med. 2009, 265(6):644-652.
38. Bresnihan B., Alvaro-Gracia J.M., Cobby M., Doherty M., Domljan Z., Emery P., et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 1998, 41(12):2196-2204.
39. Guo C., Hu F., Yi H., Feng Z., Li C., Shi L., et al. Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis. Ann. Rheum. Dis. 2014, (Epub ahead of print). 10.1136/annrheumdis-2014-205508.